Research Development - Bausch Health Companies Inc (NYSE:BHC) - Alpha Spread
B

Bausch Health Companies Inc
NYSE:BHC

Watchlist Manager
Bausch Health Companies Inc
NYSE:BHC
Watchlist
Price: 8.32 USD 0.6% Market Closed
Market Cap: 3.1B USD
Have any thoughts about
Bausch Health Companies Inc?
Write Note

Bausch Health Companies Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bausch Health Companies Inc
Research & Development Peer Comparison

Comparables:
SNDL
C
CRON
C
CURA
T
TER

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
B
Bausch Health Companies Inc
NYSE:BHC
Research & Development
-$612m
CAGR 3-Years
-11%
CAGR 5-Years
-6%
CAGR 10-Years
-10%
Sundial Growers Inc
NASDAQ:SNDL
Research & Development
-CA$324k
CAGR 3-Years
13%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
C
Cronos Group Inc
NASDAQ:CRON
Research & Development
-$4.7m
CAGR 3-Years
41%
CAGR 5-Years
2%
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Terrascend Corp
CNSX:TER
Research & Development
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Bausch Health Companies Inc's Research & Development?
Research & Development
-612m USD

Based on the financial report for Jun 30, 2024, Bausch Health Companies Inc's Research & Development amounts to -612m USD.

What is Bausch Health Companies Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-10%

Over the last year, the Research & Development growth was -7%. The average annual Research & Development growth rates for Bausch Health Companies Inc have been -11% over the past three years , -6% over the past five years , and -10% over the past ten years .

Back to Top